- June 12, 2020
- Category: Drugs and Therapeutics, Healthcare and LifeSciences
Global Lidocaine Market Size study, by Type (Powder, Gel, Cream), by Application (Cosmetics, Medicine) and Regional Forecasts 2020-2027
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million) 1.2.1. Lidocaine Market, by Region, 2018-2027 (USD Million) 1.2.2. Lidocaine Market, by Type, 2018-2027 (USD Million) 1.2.3. Lidocaine Market, by Application, 2018-2027 (USD Million) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Lidocaine Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Lidocaine Market Dynamics 3.1. Lidocaine Market Impact Analysis (2018-2027) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Lidocaine Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Lidocaine Market, by Type 5.1. Market Snapshot 5.2. Global Lidocaine Market by Type, Performance - Potential Analysis 5.3. Global Lidocaine Market Estimates & Forecasts by Type 2017-2027 (USD Million) 5.4. Lidocaine Market, Sub Segment Analysis 5.4.1. Powder 5.4.2. Gel 5.4.3. Cream Chapter 6. Global Lidocaine Market, by Application 6.1. Market Snapshot 6.2. Global Lidocaine Market by Application, Performance - Potential Analysis 6.3. Global Lidocaine Market Estimates & Forecasts by Application 2017-2027 (USD Million) 6.4. Lidocaine Market, Sub Segment Analysis 6.4.1. Cosmetics 6.4.2. Medicine Chapter 7. Global Lidocaine Market, Regional Analysis 7.1. Lidocaine Market, Regional Market Snapshot 7.2. North America Lidocaine Market 7.2.1. U.S. Lidocaine Market 126.96.36.199. Type breakdown estimates & forecasts, 2017-2027 188.8.131.52. Application breakdown estimates & forecasts, 2017-2027 7.2.2. Canada Lidocaine Market 7.3. Europe Lidocaine Market Snapshot 7.3.1. U.K. Lidocaine Market 7.3.2. Germany Lidocaine Market 7.3.3. France Lidocaine Market 7.3.4. Spain Lidocaine Market 7.3.5. Italy Lidocaine Market 7.3.6. Rest of Europe Lidocaine Market 7.4. Asia-Pacific Lidocaine Market Snapshot 7.4.1. China Lidocaine Market 7.4.2. India Lidocaine Market 7.4.3. Japan Lidocaine Market 7.4.4. Australia Lidocaine Market 7.4.5. South Korea Lidocaine Market 7.4.6. Rest of Asia Pacific Lidocaine Market 7.5. Latin America Lidocaine Market Snapshot 7.5.1. Brazil Lidocaine Market 7.5.2. Mexico Lidocaine Market 7.6. Rest of The World Lidocaine Market Chapter 8. Competitive Intelligence 8.1. Top Market Strategies 8.2. Company Profiles 8.2.1. Amneal Pharmaceuticals Inc. 184.108.40.206. Key Information 220.127.116.11. Overview 18.104.22.168. Financial (Subject to Data Availability) 22.214.171.124. Product Summary 126.96.36.199. Recent Developments 8.2.2. AstraZeneca 8.2.3. Teligent 8.2.4. Centura Pharmaceuticals 8.2.5. Taro Pharmaceutical Industries Ltd. 8.2.6. Pfizer Inc. 8.2.7. Merck KGaA 8.2.8. SCILEX Pharmaceuticals, Inc. 8.2.9. Mahendra chemicals 8.2.10. Cirondrugs Chapter 9. Research Process 9.1. Research Process 9.1.1. Data Mining 9.1.2. Analysis 9.1.3. Market Estimation 9.1.4. Validation 9.1.5. Publishing 9.2. Research Attributes 9.3. Research Assumption
Global Lidocaine Market is valued at approximately USD 893.23 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2020-2027. Lidocaine, also referred to as lignocaine, is a provincial anesthetic of the amino amide type. Lidocaine helps to reduce sharp burning pains as well as discomfort caused by skin irritations such as scratches, poison sumac, poison ivy, minor cuts, poison oak, insect bites, and sunburns. Further, lidocaine’s local painkiller action foresees its use in extensive medicinal circumstances or situations that may benefit from its action, involving the treatment of impulsive ejaculation, which may reinforce the demand for lidocaine market all over the world. Also, it is frequently used in dental procedure and cosmetic surgery, for laser resurfacing after 20 minutes without occlusion. Thus, rising cosmetic surgical procedures has increased the demand for lidocaine which is primarily drives the growth of the market. For instance: as per the Victorian Cosmetic Institute, the total number of cosmetic surgical procedures in Australia estimated at around 1,790,832 in 2017 and is increased to nearly 1,811,740 in 2018. Similarly, as of 2018, nearly 53,028 Australian had done neck lifting surgery and has risen to 53,571 number of people undergone through neck lifting surgical procedure in 2019. Moreover, Lidocaine is commonly used for its anti-inflammatory actions to reduce cough and improve respiratory symptoms in severe asthmatic patients. Thus, increasing cases of chronic disease, followed by the rising geriatric population resulting in encouraging the demand for lidocaine; therefore, propelling the growth of the market. According to National Center for Biotechnology Information, generally, 33% of Chinese and 49% of Indian respondents aged 50 and older reported at least one chronic condition. As per Statista, the number of people with asthma in Australia were 2013.5 thousand people in 2005 and has risen to 2705.1 thousand peoples suffering from asthma in 2018. This, in turn, is likely to strengthen the demand for Lidocaine, thereby contributing to the market growth around the world. However, the strict regulatory standards for lidocaine is one of the prime factors restraining the market growth over the forecast period of 2020-2027.
The regional analysis of the global Lidocaine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing demand for lidocaine formulations, along with the wide presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in number of cometic procedures and dental procedures coupled with increasing awareness regarding lidocaine among medical practitioners in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Lidocaine market in the Asia-Pacific region.
Major market player included in this report are:
Amneal Pharmaceuticals Inc.
Taro Pharmaceutical Industries Ltd.
SCILEX Pharmaceuticals, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Lidocaine Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers